first large study of glp 1 receptor agonists during pregnancy GLP-1 Agonist Exposure Pregnancy: A Systematic Review and Meta-Analysis Adverse Outcomes Discontinuing GLP-1s before or early
Description
GLP-1, a 36-amino acid peptide, is produced in enteroendocrine L-cells of the distal small bowel and colon (92)
With the continuous progress of drug research and development, it has brought more effective, more convenient means of treatment
No needles, no strict timing, and less stress
A Reuters analysis of earnings transcripts revealed that mentions of GLP-1 and related terms doubled from 127 in Q2 2023 to 256 mentions in Q3 across 29 U.S
however, to our knowledge, no larger clinical trials with GLP-1 RAs in HFrEF are ongoing
Schade DS, Eaton RP
